Search Results

There are 14674 results for: content related to: Risk factors in neuroleptic malignant syndrome. A case–control study

  1. Neuroleptic Malignant Syndrome

    Drug Induced Movement Disorders, Second Edition

    Stewart A. Factor, Anthony E. Lang, William J. Weiner, Pages: 174–212, 2008

    Published Online : 14 JAN 2008, DOI: 10.1002/9780470753217.ch8

  2. Retrospective chart review on exposure to psychotropic medications associated with neuroleptic malignant syndrome

    Acta Psychiatrica Scandinavica

    Volume 130, Issue 1, July 2014, Pages: 52–60, Y.-P. Su, C.-K. Chang, R. D. Hayes, S. Harrison, W. Lee, M. Broadbent, D. Taylor and R. Stewart

    Version of Record online : 15 NOV 2013, DOI: 10.1111/acps.12222

  3. Neuroleptic malignant syndrome: risk factors, pathophysiology, and treatment

    Acta Neuropsychiatrica

    Volume 16, Issue 4, August 2004, Pages: 219–228, Jambur Ananth, Kamala Aduri, Sharath Parameswaran and Sarath Gunatilake

    Version of Record online : 9 DEC 2004, DOI: 10.1111/j.0924-2708.2004.00085.x

  4. Electroconvulsive treatment of neuroleptic malignant syndrome: a review and report of cases

    Australian and New Zealand Journal of Psychiatry

    Volume 33, Issue 5, October 1999, Pages: 650–659, Julian N. Trollor and Perminder S. Sachdev

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1440-1614.1999.00630.x

  5. Rediscovering catatonia: the biography of a treatable syndrome

    Acta Psychiatrica Scandinavica

    Volume 127, Issue s441, January 2013, Pages: 1–47, Max Fink

    Version of Record online : 5 DEC 2012, DOI: 10.1111/acps.12038

  6. Clinical risk factors for neuroleptic malignant syndrome

    Human Psychopharmacology: Clinical and Experimental

    Volume 17, Issue 2, March 2002, Pages: 99–102, Domenico Berardi, Maddalena Dell'Atti, Mario Amore, Diana De Ronchi and Giuseppe Ferrari

    Version of Record online : 7 FEB 2002, DOI: 10.1002/hup.376

  7. Atypical Neuroleptic Malignant Syndrome: Diagnostic Controversies and Considerations

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 4, April 2008, Pages: 530–535, Dr. Lara S. Picard, Dr. Shane Lindsay, Dr. Jeffrey R. Strawn, Dr. Rakesh M. Kaneria, Dr. Nick C. Patel and Dr. Paul E. Keck Jr.

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.4.530

  8. Recognizing Neuroleptic Malignant Syndrome in the Emergency Department: A Case Study

    Perspectives in Psychiatric Care

    Volume 46, Issue 2, April 2010, Pages: 143–151, Lynne Agar

    Version of Record online : 25 MAR 2010, DOI: 10.1111/j.1744-6163.2010.00250.x

  9. You have free access to this content
    Clinical and pharmacologic risk factors for neuroleptic malignant syndrome and their association with death

    Psychiatry and Clinical Neurosciences

    Volume 64, Issue 1, February 2010, Pages: 79–87, Ümit Tural and Emin Önder

    Version of Record online : 20 JAN 2010, DOI: 10.1111/j.1440-1819.2009.02042.x

  10. You have free access to this content
    The treatment of neuroleptic malignant syndrome using dantrolene sodium

    Psychiatry and Clinical Neurosciences

    Volume 52, Issue 4, July 1998, Pages: 433–438, YASUHIKO TSUTSUMI, KENJI YAMAMOTO, SHINSUKE MATSUURA, SHUNJI HATA, MASAO SAKAI and KATSUYUKI SHIRAKURA

    Version of Record online : 23 SEP 2008, DOI: 10.1046/j.1440-1819.1998.00416.x

  11. Neuroleptic malignant syndrome: Mechanisms, interactions, and causality

    Movement Disorders

    Volume 25, Issue 12, 15 September 2010, Pages: 1780–1790, P. Ken Gillman

    Version of Record online : 9 JUL 2010, DOI: 10.1002/mds.23220

  12. Olanzapine-Associated Neuroleptic Malignant Syndrome in a Patient Receiving Concomitant Rivastigmine Therapy

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 28, Issue 3, March 2008, Pages: 403–405, Dr. Debra L. Stevens, Dr. Matthew R. Lee and Dr. Yolanda Padua

    Version of Record online : 6 JAN 2012, DOI: 10.1592/phco.28.3.403

  13. Atypical Neuroleptic Malignant Syndrome Associated with Olanzapine

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 5, May 2002, Pages: 641–644, Roy R. Reeves, Raphael A. Torres, Vincent Liberto and Roy H. Hart

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.8.641.33211

  14. Postoperative neuroleptic malignant syndrome that occurred repeatedly in a patient with cerebral palsy

    Pediatric Anesthesia

    Volume 17, Issue 3, March 2007, Pages: 281–284, NAOHISA TSUCHIYA, ERI MORIMURA, TETSUJI HANAFUSA and TETSUTARO SHINOMURA

    Version of Record online : 29 SEP 2006, DOI: 10.1111/j.1460-9592.2006.02079.x

  15. The neuroleptic malignant syndrome: agent and host interaction

    Acta Psychiatrica Scandinavica

    Volume 73, Issue 4, April 1986, Pages: 337–347, A. Shalev and H. Munitz

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1986.tb02694.x

  16. Are Neuroleptic Malignant Syndrome and Serotonin Syndrome the Same Syndrome?

    Perspectives in Psychiatric Care

    Volume 47, Issue 1, January 2011, Pages: 58–62, Debbie Steele, Norman L. Keltner and Teena M. McGuiness

    Version of Record online : 14 DEC 2010, DOI: 10.1111/j.1744-6163.2010.00292.x

  17. Olanzapine induced neuroleptic malignant syndrome—a case review

    Human Psychopharmacology: Clinical and Experimental

    Volume 18, Issue 4, June 2003, Pages: 301–309, Aleš Kogoj and Ingrid Velikonja

    Version of Record online : 5 MAR 2003, DOI: 10.1002/hup.483

  18. Incidence and risk factors in neuroleptic malignant syndrome

    Acta Psychiatrica Scandinavica

    Volume 90, Issue 6, December 1994, Pages: 424–426, H. Naganuma and I. Fujii

    Version of Record online : 23 AUG 2007, DOI: 10.1111/j.1600-0447.1994.tb01618.x

  19. Zotepine-Induced Catatonia as a Precursor in the Progression to Neuroleptic Malignant Syndrome

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 25, Issue 8, August 2005, Pages: 1156–1159, Dr. Jui-Hsiu Tsai, Dr. Pinchen Yang, Dr. Ju-Yu Yen, Dr. Cheng-Chung Chen and Dr. Ming-Jen Yang

    Version of Record online : 16 JAN 2012, DOI: 10.1592/phco.2005.25.8.1156

  20. Neuroleptic Malignant Syndrome with Risperidone

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 3, May-June 1997, Pages: 617–621, Dr. Patrick P. Gleason and Dr. Rosemarie L. Conigliaro

    Version of Record online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03074.x